Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Raibaut

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Chemical Science|July 19, 2017
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent <i>in vivo</i> MET receptor agonistClaire Simonneau, Bérénice Leclercq, Alexandra Mougel, et al.
Metallomics : Integrated Biometal Science|April 13, 2024
Quest for a stable Cu-ligand complex with a high catalytic activity to produce reactive oxygen speciesMerwan Bouraguba, Adeline M Schmitt, Venkata Suseela Yelisetty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2023
Evaluation of Candidate Theranostics for <sup>227</sup>Th/<sup>89</sup>Zr Paired Radioimmunotherapy of LymphomaDiane S Abou, Mark Longtine, Amanda Fears, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Chemical Science|July 19, 2017
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent <i>in vivo</i> MET receptor agonistClaire Simonneau, Bérénice Leclercq, Alexandra Mougel, et al.
Metallomics : Integrated Biometal Science|April 13, 2024
Quest for a stable Cu-ligand complex with a high catalytic activity to produce reactive oxygen speciesMerwan Bouraguba, Adeline M Schmitt, Venkata Suseela Yelisetty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2023
Evaluation of Candidate Theranostics for <sup>227</sup>Th/<sup>89</sup>Zr Paired Radioimmunotherapy of LymphomaDiane S Abou, Mark Longtine, Amanda Fears, et al.
Pageof 4